IVP · As filed with the SEC
Inspire Veterinary Partners balance sheet, by quarter
The statement as Inspire Veterinary Partners presents it in its 10-Q and 10-K: its own lines, labels and order. Tables over time lines up standardized figures across every filing.
Unaudited Condensed Consolidated Balance Sheets · USD
| USD | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 |
|---|---|---|---|---|
| Assets | ||||
| Current assets: | ||||
| Cash and cash equivalents | — | — | — | 523,690 |
| Cash and cash equivalents | 341,746 | 158,942 | 1,738,033 | — |
| Accounts receivable, net | 28,704 | 183,634 | 4,376 | 40,675 |
| Inventory | 497,614 | 476,991 | 475,152 | 516,650 |
| Investments – equity securities | 2,571,429 | — | — | — |
| Prepaid expenses and other current assets | 385,055 | 513,647 | 683,687 | 942,456 |
| Total current assets | 3,824,548 | 1,333,214 | 2,901,248 | 2,023,471 |
| Restricted cash - non-current | 234,500 | 234,500 | 120,000 | 200,000 |
| Property and equipment, net | 6,889,958 | 7,025,647 | 6,280,246 | 6,382,788 |
| Right-of-use assets | 1,695,171 | 1,748,589 | 1,802,006 | 1,879,729 |
| Intangibles assets | 1,175,099 | 1,426,446 | 1,481,352 | 1,633,927 |
| Goodwill | 9,088,263 | 8,988,263 | 8,022,082 | 8,022,082 |
| Deferred financing costs | 1,000,000 | — | — | — |
| Other assets | 48,227 | 53,997 | 53,997 | 53,997 |
| Total assets | 23,955,766 | 20,810,656 | 20,660,931 | 20,195,994 |
| Liabilities and Stockholder’s Deficit | ||||
| Current liabilities: | ||||
| Accounts payable | 1,700,265 | 1,875,438 | 1,769,991 | 1,979,503 |
| Accrued expenses | 969,940 | 1,013,364 | 643,311 | 285,770 |
| Operating lease liabilities | 170,774 | 166,945 | 163,193 | 183,981 |
| Loans payable, net of discount | 2,057,740 | 2,738,871 | 1,737,846 | 2,340,020 |
| Convertible notes payable | 274,908 | 258,393 | — | — |
| Promissory note | 1,120,623 | 511,682 | — | — |
| Notes payable, net of discount | — | 3,486,268 | 3,157,641 | 3,410,465 |
| Notes payable, net of discount | 3,424,599 | — | — | — |
| Total current liabilities | 9,718,849 | 10,050,961 | 7,471,982 | 8,199,739 |
| Operating lease liabilities, non-current | 1,813,828 | 1,857,960 | 1,901,083 | 1,943,487 |
| Notes payable - noncurrent | 8,254,408 | 8,455,473 | 8,283,910 | 8,490,763 |
| Total liabilities | 19,787,085 | 20,364,394 | 17,656,975 | 18,633,989 |
| Stockholder’s Equity (Deficit) | ||||
| Class A | 360 | 231 | 211 | 117 |
| Class B | 302 | 302 | 302 | 302 |
| Convertible Series B | 1 | — | — | — |
| Additional paid in capital | 48,494,176 | 42,245,614 | 41,768,760 | 37,911,867 |
| Accumulated deficit | (44,326,158) | (41,799,885) | (38,765,317) | (36,350,281) |
| Total stockholder’s equity (deficit) | 4,168,681 | 446,262 | 3,003,956 | 1,562,005 |
| Total liabilities and stockholder’s equity (deficit) | 23,955,766 | 20,810,656 | 20,660,931 | 20,195,994 |
As filed on EDGAR · Not affiliated with the U.S. SEC · Not investment advice. Each column links to its filing.